Recombinant COVID-19 Vaccine (Sf9 Cell)
WSKCT004
Unknown mab completed
Quick answer
Recombinant COVID-19 Vaccine (Sf9 Cell) for COVID-19 is a Unknown program (mab) at Xiyuan Hospital of China Academy of Chinese Medical Sciences with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Xiyuan Hospital of China Academy of Chinese Medical Sciences
- Indication
- COVID-19
- Phase
- Unknown
- Modality
- mab
- Status
- completed